Your browser doesn't support javascript.
loading
Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma.
Williams, AnnaLynn M; Mirzaei Salehabadi, Sedigheh; Xing, Mengqi; Phillips, Nicholas S; Ehrhardt, Matthew J; Howell, Rebecca; Yasui, Yutaka; Oeffinger, Kevin C; Gibson, Todd; Chow, Eric J; Leisenring, Wendy; Srivastava, Deokumar; Hudson, Melissa M; Robison, Leslie L; Armstrong, Gregory T; Krull, Kevin R.
Afiliación
  • Williams AM; Department of Epidemiology and Cancer Control.
  • Mirzaei Salehabadi S; Department of Biostatistics, and.
  • Xing M; Department of Biostatistics, and.
  • Phillips NS; Department of Epidemiology and Cancer Control.
  • Ehrhardt MJ; Department of Epidemiology and Cancer Control.
  • Howell R; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Yasui Y; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Oeffinger KC; Department of Epidemiology and Cancer Control.
  • Gibson T; Department of Medicine, Duke University and Duke Cancer Institute, Durham, NC.
  • Chow EJ; Division of Cancer Epidemiology and Genetics, Radiation Epidemiology Branch, National Cancer Institute, Rockville, MD.
  • Leisenring W; Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Srivastava D; Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
  • Hudson MM; Department of Biostatistics, and.
  • Robison LL; Department of Epidemiology and Cancer Control.
  • Armstrong GT; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Krull KR; Department of Epidemiology and Cancer Control.
Blood ; 139(20): 3073-3086, 2022 05 19.
Article en En | MEDLINE | ID: mdl-34861035
ABSTRACT
Long-term survivors of childhood Hodgkin lymphoma (HL) experience a high burden of chronic health morbidities. Correlates of neurocognitive and psychosocial morbidity have not been well established. A total of 1760 survivors of HL (mean ± SD age, 37.5 ± 6.0 years; time since diagnosis, 23.6 ± 4.7 years; 52.1% female) and 3180 siblings (mean age, 33.2 ± 8.5 years; 54.5% female) completed cross-sectional surveys assessing neurocognitive function, emotional distress, quality of life, social attainment, smoking, and physical activity. Treatment exposures were abstracted from medical records. Chronic health conditions were graded according to the National Cancer Institute's Common Terminology Criteria for Adverse Events version 4.3 (1 = mild, 2 = moderate, 3 = severe/disabling, and 4 = life-threatening). Multivariable analyses, adjusted for age, sex, and race, estimated relative risk (RR) of impairment in survivors vs siblings and, among survivors, risk of impairment associated with demographic, clinical, treatment, and grade 2 or higher chronic health conditions. Compared with siblings, survivors had significantly higher risk (all, P < .05) of neurocognitive impairment (eg, memory, 8.1% vs 5.7%), anxiety (7.0% vs 5.4%), depression (9.1% vs 7%), unemployment (9.6% vs 4.4%), and impaired physical/mental quality of life (eg, physical function, 11.2% vs 3.0%). Smoking was associated with a higher risk of impairment in task efficiency (RR, 1.56; 95% confidence interval [CI], 1.02-2.39), emotional regulation (RR, 1.84; 95% CI, 1.35-2.49), anxiety (RR, 2.43; 95% CI, 1.51-3.93), and depression (RR, 2.73; 95% CI, 1.85-4.04). Meeting the exercise guidelines of the Centers for Disease Control and Prevention was associated with a lower risk of impairment in task efficiency (RR, 0.70; 95% CI, 0.52-0.95), organization (RR, 0.60; 95% CI, 0.45-0.80), depression (RR, 0.66; 95% CI, 0.48-0.92), and multiple quality of life domains. Cardiovascular and neurologic conditions were associated with impairment in nearly all domains. Survivors of HL are at elevated risk for neurocognitive and psychosocial impairment, and risk is associated with modifiable factors that provide targets for interventions to improve long-term functional outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Neoplasias Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Neoplasias Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article